Home / Companies / Zydus Lifesciences Limited / 12 Aug 2025
Zydus Lifesciences Limited: meeting of 12 Aug 2025
Votes reported on Form N-PX, item by item
69 Form N-PX filers reported votes at the Zydus Lifesciences Limited meeting of 12 Aug 2025. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 98.6% of reported votes for; 2 filers withheld from or voted against at least one nominee.
214 vote records from 69 filers. 2 of the 69 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
145 vote records from 69 filers. 1 of the 69 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
112 vote records from 69 filers. 0 of the 69 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
89 vote records from 58 filers. 0 of the 58 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
212 vote records from 63 filers. 0 of the 63 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
12 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | For | For |
| State Street and SPDR | For | For |
| American Century | For | For |
| Franklin Templeton | For | For |
| Invesco | For | For |
| Equitable | For | Abstain or withhold * |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| J.P. Morgan | For | For |
| Goldman Sachs | For | For |
| WisdomTree | For | For |
| PGIM and Prudential | For | For |
| Jackson National funds | For | For |
| Northern Trust and FlexShares | For | For |
| Thrivent | For | For |
| Lincoln Financial | For | For |
| Voya | Against * | For |
| Russell Investments | For | For |
| Nationwide | For | For |
| Victory Capital | For | For |
| Brighthouse Funds | For | For |
| BNY Mellon | For | For |
| Pacific Life funds | For | For |
| Federated Hermes | For | For |
| Hartford Funds | Against * | For |
| PIMCO | For | For |
| VanEck | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Zydus Lifesciences Limited meeting?
69 Form N-PX filers reported votes at the meeting of 12 Aug 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Zydus Lifesciences Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Zydus Lifesciences Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Zydus Lifesciences Limited with a meeting date within three days of 12 Aug 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.